Retrospective cohort analysis of Blue-Light cystoscopy using a claims database.
@MarkTysonMD @MayoClinic joins
@UroDocAsh @UTMDAnderson reviewing a real-world cost analysis of blue-light versus white-light cystoscopy, drawing on a matched Optum database cohort. Dr. Tyson notes the PHOTO trial found similar recurrence-free survival with higher costs in predominantly intermediate-risk patients. #
WatchNow# on UroToday >